Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GPSM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TPGS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MDH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGKC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NPRL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADGRL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUMB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EGR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLFN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRABD2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BBX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CMTM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on